Breast Cancer and Hormone Replacement Therapy
Many women who took a combination hormone replacement therapy drug—estrogen and progestin, e.g., Prempro, et. al.—ceased their medication back in July, 2002, when a major clinical trial showed that these HRT drugs seemed to be a breast cancer risk factor. Another study, released in December, 2006, reinforced that belief. And a further... Read more
